Valion Bio, Inc. — Form 8-K/A
Filed August 20, 2026 · analyzed by the 8-K Agent
8-K/A
— Neutral
significance 8/100
What the filing says
Valion Bio filed an 8-K/A (amended current report) on August 20, 2026, covering Item 5.07 (Submission of Matters to a Vote of Security Holders) with a period of report date of August 14, 2026. The filing is procedural and amends a prior 8-K; the specific details of the shareholder vote matter are not disclosed in the header information provided.
Why this rating
Amended disclosure of shareholder vote is routine procedural filing; no material transaction, financial impact, or operational change disclosed. Neutral for micro-cap.
Extracted items
See more from August 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.